Latest Insider Transactions at Xtant Medical Holdings, Inc. (XTNT)
This section provides a real-time view of insider transactions for Xtant Medical Holdings, Inc. (XTNT). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Xtant Medical Holdings, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Xtant Medical Holdings, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Aug 15
2024
|
Stavros G. Vizirgianakis Director |
BUY
Grant, award, or other acquisition
|
Direct |
748,648
+5.2%
|
-
|
|
Aug 15
2024
|
Lori D Mitchell Keller Director |
BUY
Grant, award, or other acquisition
|
Direct |
162,162
+31.47%
|
-
|
|
Aug 15
2024
|
Robert Mc Namara Director |
BUY
Grant, award, or other acquisition
|
Direct |
162,162
+17.7%
|
-
|
|
Aug 15
2024
|
Jonn R. Beeson Director |
BUY
Grant, award, or other acquisition
|
Direct |
162,162
+31.09%
|
-
|
|
Aug 15
2024
|
John K Bakewell Director |
BUY
Grant, award, or other acquisition
|
Direct |
162,162
+17.66%
|
-
|
|
Aug 15
2024
|
Kevin D Brandt Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
56,333
-5.63%
|
$0
$0.6 P/Share
|
|
Aug 15
2024
|
Scott C Neils Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
34,132
-5.14%
|
$0
$0.6 P/Share
|
|
Aug 15
2024
|
Sean E Browne President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
10,606
-0.46%
|
$0
$0.6 P/Share
|
|
Apr 03
2024
|
Kevin D Brandt Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
184,209
+15.55%
|
-
|
|
Apr 03
2024
|
Sean E Browne President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
731,632
+24.08%
|
-
|
|
Apr 03
2024
|
Mark A. Schallenberger Chief Operations Officer |
BUY
Grant, award, or other acquisition
|
Direct |
177,551
+31.69%
|
-
|
|
Apr 03
2024
|
Scott C Neils Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
177,551
+21.09%
|
-
|
|
Jan 16
2024
|
Scott C Neils Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
7,986
-1.61%
|
$7,986
$1.09 P/Share
|
|
Nov 17
2023
|
Kevin D Brandt Chief Commercial Officer |
BUY
Open market or private purchase
|
Direct |
41,670
+4.86%
|
$41,670
$1.2 P/Share
|
|
Oct 15
2023
|
Sean E Browne President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
111,721
-6.65%
|
$111,721
$1.08 P/Share
|
|
Aug 15
2023
|
Mark A. Schallenberger Chief Operations Officer |
BUY
Grant, award, or other acquisition
|
Direct |
116,144
+36.15%
|
-
|
|
Aug 15
2023
|
Scott C Neils Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
25,246
-4.85%
|
$25,246
$1.18 P/Share
|
|
Aug 15
2023
|
Scott C Neils Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
116,144
+18.25%
|
-
|
|
Aug 15
2023
|
Sean E Browne President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
174,216
+9.39%
|
-
|
|
Aug 15
2023
|
Kevin D Brandt Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
49,880
-6.05%
|
$49,880
$1.18 P/Share
|
|
Aug 15
2023
|
Kevin D Brandt Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
120,499
+12.76%
|
-
|
|
Aug 15
2023
|
Stavros G. Vizirgianakis Director |
BUY
Grant, award, or other acquisition
|
Direct |
217,770
+3.39%
|
-
|
|
Aug 15
2023
|
Lori D Mitchell Keller Director |
BUY
Grant, award, or other acquisition
|
Direct |
145,180
+43.19%
|
-
|
|
Aug 15
2023
|
Robert Mc Namara Director |
BUY
Grant, award, or other acquisition
|
Direct |
145,180
+19.69%
|
-
|
|
Aug 15
2023
|
Jonn R. Beeson Director |
BUY
Grant, award, or other acquisition
|
Direct |
145,180
+42.4%
|
-
|
|
Aug 15
2023
|
John K Bakewell Director |
BUY
Grant, award, or other acquisition
|
Direct |
145,180
+19.65%
|
-
|
|
Jun 15
2023
|
Lori D Mitchell Keller Director |
BUY
Grant, award, or other acquisition
|
Direct |
45,782
+50.0%
|
-
|
|
May 15
2023
|
Jonn R. Beeson Director |
BUY
Grant, award, or other acquisition
|
Direct |
52,049
+50.0%
|
-
|
|
Feb 15
2023
|
Mark A. Schallenberger Chief Operations Officer |
BUY
Grant, award, or other acquisition
|
Direct |
89,000
+50.0%
|
-
|
|
Jan 18
2023
|
Scott C Neils Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
8,673
-2.1%
|
$0
$0.61 P/Share
|
|
Nov 15
2022
|
Stavros G. Vizirgianakis Director |
BUY
Grant, award, or other acquisition
|
Direct |
144,639
+2.36%
|
-
|
|
Oct 19
2022
|
Sean E Browne President and CEO |
SELL
Open market or private sale
|
Direct |
51,100
-3.28%
|
$0
$0.62 P/Share
|
|
Oct 18
2022
|
Sean E Browne President and CEO |
SELL
Open market or private sale
|
Direct |
80,000
-4.88%
|
$0
$0.68 P/Share
|
|
Oct 07
2022
|
Stavros G. Vizirgianakis Director |
BUY
Open market or private purchase
|
Direct |
2,264,861
+27.91%
|
$0
$0.48 P/Share
|
|
Aug 25
2022
|
Stavros G. Vizirgianakis Director |
BUY
Grant, award, or other acquisition
|
Direct |
70,776
+1.94%
|
-
|
|
Aug 17
2022
|
Scott C Neils Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
1,270
-0.31%
|
$0
$0.48 P/Share
|
|
Aug 17
2022
|
Kevin D Brandt Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
4,300
-0.61%
|
$0
$0.48 P/Share
|
|
Aug 16
2022
|
Scott C Neils Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
5,100
-1.22%
|
$0
$0.48 P/Share
|
|
Aug 16
2022
|
Kevin D Brandt Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
18,700
-2.57%
|
$0
$0.49 P/Share
|
|
Aug 15
2022
|
Matthew Rizzo Director |
BUY
Grant, award, or other acquisition
|
Direct |
215,415
+50.0%
|
-
|
|
Aug 15
2022
|
Jeffrey J Peters Director |
BUY
Grant, award, or other acquisition
|
Direct |
215,415
+32.44%
|
-
|
|
Aug 15
2022
|
Orbimed Advisors LLC Director |
BUY
Other acquisition or disposition
|
Indirect |
430,830
+50.0%
|
-
|
|
Aug 15
2022
|
Scott C Neils Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
251,895
+37.55%
|
-
|
|
Aug 15
2022
|
Robert Mc Namara Director |
BUY
Grant, award, or other acquisition
|
Direct |
215,415
+32.53%
|
-
|
|
Aug 15
2022
|
Michael Eggenberg Director |
BUY
Grant, award, or other acquisition
|
Direct |
215,415
+50.0%
|
-
|
|
Aug 15
2022
|
Kevin D Brandt Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
410,079
+36.08%
|
-
|
|
Aug 15
2022
|
John K Bakewell Director |
BUY
Grant, award, or other acquisition
|
Direct |
215,415
+32.44%
|
-
|
|
Jan 15
2022
|
Scott C Neils Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
88,983
+34.75%
|
-
|
|
Oct 15
2021
|
Sean E Browne President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
160,219
-8.91%
|
$160,219
$1.11 P/Share
|
|
Aug 15
2021
|
Greg Jensen Vice President, Finance & CFO |
BUY
Grant, award, or other acquisition
|
Direct |
156,250
+35.38%
|
-
|